186 related articles for article (PubMed ID: 9155518)
21. BRCA1 protein expression and its correlation with ER/PR status in sporadic and familial breast cancer in Eastern Indian patients--a hospital based study.
Ashraf M; Jha JK; Mukherjee N; Panda CK; Nayak S; Jadhav TS; Dikshit N; Nath NC; Chakraborty J; Biswas J
J Indian Med Assoc; 2011 Dec; 109(12):873-8. PubMed ID: 23469566
[TBL] [Abstract][Full Text] [Related]
22. Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula.
Vega A; Torres M; Martínez JI; Ruiz-Ponte C; Barros F; Carracedo A
Ann Hum Genet; 2002 Jan; 66(Pt 1):29-36. PubMed ID: 12014998
[TBL] [Abstract][Full Text] [Related]
23. A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer.
Einbeigi Z; Bergman A; Kindblom LG; Martinsson T; Meis-Kindblom JM; Nordling M; Suurküla M; Wahlström J; Wallgren A; Karlsson P
Eur J Cancer; 2001 Oct; 37(15):1904-9. PubMed ID: 11576847
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
Boyd J; Sonoda Y; Federici MG; Bogomolniy F; Rhei E; Maresco DL; Saigo PE; Almadrones LA; Barakat RR; Brown CL; Chi DS; Curtin JP; Poynor EA; Hoskins WJ
JAMA; 2000 May; 283(17):2260-5. PubMed ID: 10807385
[TBL] [Abstract][Full Text] [Related]
26. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.
Lancaster JM; Carney ME; Gray J; Myring J; Gumbs C; Sampson J; Wheeler D; France E; Wiseman R; Harper P; Futreal PA
Br J Cancer; 1998 Dec; 78(11):1417-20. PubMed ID: 9836472
[TBL] [Abstract][Full Text] [Related]
28. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.
Wagner TM; Möslinger RA; Muhr D; Langbauer G; Hirtenlehner K; Concin H; Doeller W; Haid A; Lang AH; Mayer P; Ropp E; Kubista E; Amirimani B; Helbich T; Becherer A; Scheiner O; Breiteneder H; Borg A; Devilee P; Oefner P; Zielinski C
Int J Cancer; 1998 Jul; 77(3):354-60. PubMed ID: 9663595
[TBL] [Abstract][Full Text] [Related]
29. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of hereditary ovarian cancer (HOC) in Poland.
Menkiszak J; Górski B; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Fliciński J; Brzosko M; Rzepka-Górska I; Lubiński J
Ginekol Pol; 2002 Sep; 73(9):733-9. PubMed ID: 12602271
[TBL] [Abstract][Full Text] [Related]
31. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
32. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
Bianco T; Chenevix-Trench G; Walsh DC; Cooper JE; Dobrovic A
Carcinogenesis; 2000 Feb; 21(2):147-51. PubMed ID: 10657950
[TBL] [Abstract][Full Text] [Related]
33. No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.
Aghmesheh M; Nesland JM; Kaern J; Dorum A; Edwards L; Byth K; Friedlander M; Jackson P; Tucker KM; Russell PJ
Gynecol Oncol; 2004 Dec; 95(3):430-6. PubMed ID: 15581943
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 and BRCA2 mutations in central and southern Italian patients.
Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R
Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688
[TBL] [Abstract][Full Text] [Related]
35. The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.
Møller P; Borg A; Heimdal K; Apold J; Vallon-Christersson J; Hovig E; Maehle L; ;
Eur J Cancer; 2001 May; 37(8):1027-32. PubMed ID: 11334729
[TBL] [Abstract][Full Text] [Related]
36. Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome.
Menendez JA; Folguera-Blasco N; Cuyàs E; Fernández-Arroyo S; Joven J; Alarcón T
Oncotarget; 2016 Mar; 7(11):11959-71. PubMed ID: 26943589
[TBL] [Abstract][Full Text] [Related]
37. [Germ-line mutations of the BRCA1 gene in northeastern France].
Fricker JP; Muller D; Cutuli B; Rodier JF; Janser JC; Jung GM; Mors R; Petit T; Haegele P; Abecassis J
Bull Cancer; 2000 Oct; 87(10):739-44. PubMed ID: 11084537
[TBL] [Abstract][Full Text] [Related]
38. Novel BRCA1/2 mutations in Serbian breast and breast-ovarian cancer patients with hereditary predisposition.
Dobricić J; Branković-Magić M; Filipović S; Radulović S
Cancer Genet Cytogenet; 2010 Oct; 202(1):27-32. PubMed ID: 20804917
[TBL] [Abstract][Full Text] [Related]
39. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
[TBL] [Abstract][Full Text] [Related]
40. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
